Current MaxCyte forecasts and price targets in July 2026
Ø Analyst Price Targets
6.47 USD
+44,383.64 %
Median
5.83 USD
+40,008.20 %
Max
9.45 USD
Min
5.05 USD
Last Price
0.01 USD
Buy
10
Hold
3
Sell
0
The average target price for MaxCyte is 6.47 USD. (+44,383.64 % above the current price)
The median price target of MaxCyte is 5.83 USD.
Stock analysts from many renowned investment banks are closely examining the MaxCyte stock. They conclude their professional MaxCyte stock analyses with a clear recommendation for the MaxCyte stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 10 | 3 | 0 | 6.47 USD |
| 2026-01-01 | 10 | 3 | 0 | 6.47 USD |
| 2025-12-01 | 10 | 3 | 0 | 6.47 USD |
| 2025-12-01 | 10 | 3 | 0 | 6.47 USD |
| 2025-11-01 | 10 | 3 | 0 | 6.47 USD |
| 2025-11-01 | 10 | 3 | 0 | 6.47 USD |
MaxCyte Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for MaxCyte in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 35.00 M USD | -43.00 M USD | -0.41 USD |
| 2026e | 39.00 M USD | -29.00 M USD | -0.28 USD |
| 2027e | 47.00 M USD | -23.00 M USD | -0.22 USD |